These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of muscarinic M Stoll K; Hart R; Lindsley CW; Thomsen M Psychopharmacology (Berl); 2018 Mar; 235(3):815-827. PubMed ID: 29250738 [TBL] [Abstract][Full Text] [Related]
4. Acute and chronic effects of the M1/M4-preferring muscarinic agonist xanomeline on cocaine vs. food choice in rats. Thomsen M; Fulton BS; Caine SB Psychopharmacology (Berl); 2014 Feb; 231(3):469-79. PubMed ID: 23995301 [TBL] [Abstract][Full Text] [Related]
5. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M Joseph L; Thomsen M Behav Brain Res; 2017 Jun; 329():75-83. PubMed ID: 28442355 [TBL] [Abstract][Full Text] [Related]
6. The M1/M4 preferring agonist xanomeline is analgesic in rodent models of chronic inflammatory and neuropathic pain via central site of action. Martino G; Puma C; Yu XH; Gilbert AK; Coupal M; Markoglou N; McIntosh FS; Perkins MN; Laird JMA Pain; 2011 Dec; 152(12):2852-2860. PubMed ID: 22018972 [TBL] [Abstract][Full Text] [Related]
7. In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M Mandai T; Kasahara M; Kurimoto E; Tanaka M; Suzuki M; Nakatani A; Kimura H Neuroscience; 2019 Aug; 414():60-76. PubMed ID: 31299348 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice. Woolley ML; Carter HJ; Gartlon JE; Watson JM; Dawson LA Eur J Pharmacol; 2009 Jan; 603(1-3):147-9. PubMed ID: 19111716 [TBL] [Abstract][Full Text] [Related]
9. Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys. Bowen CA; Negus SS; Zong R; Neumeyer JL; Bidlack JM; Mello NK Neuropsychopharmacology; 2003 Jun; 28(6):1125-39. PubMed ID: 12637953 [TBL] [Abstract][Full Text] [Related]
10. Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice. Thomsen M; Caine SB Eur J Pharmacol; 2016 Apr; 776():71-80. PubMed ID: 26874213 [TBL] [Abstract][Full Text] [Related]
11. Modulation of cocaine's discriminative stimulus effects by dopamine D(1) agonists in rhesus monkeys. Sinnott RS; Nader MA Pharmacol Biochem Behav; 2001 Feb; 68(2):301-9. PubMed ID: 11267635 [TBL] [Abstract][Full Text] [Related]
12. The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia. Barak S; Weiner I Int J Neuropsychopharmacol; 2011 Oct; 14(9):1233-46. PubMed ID: 21211109 [TBL] [Abstract][Full Text] [Related]
13. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists. Costanza RM; Barber DJ; Terry P Psychopharmacology (Berl); 2001 Nov; 158(2):146-53. PubMed ID: 11702088 [TBL] [Abstract][Full Text] [Related]
14. Effects of dopamine D(2)-like receptor agonists in mice trained to discriminate cocaine from saline: influence of feeding condition. Collins GT; Jackson JA; Koek W; France CP Eur J Pharmacol; 2014 Apr; 729():123-31. PubMed ID: 24561049 [TBL] [Abstract][Full Text] [Related]
15. Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice. Thomsen M; Wess J; Fulton BS; Fink-Jensen A; Caine SB Psychopharmacology (Berl); 2010 Feb; 208(3):401-16. PubMed ID: 20013114 [TBL] [Abstract][Full Text] [Related]